| PERIOD ENDING | 31-Mar-03 | 31-Dec-02 | 30-Sep-02 | 30-Jun-02 | | Total Revenue | 1,010 | 61,191 | 35,880 | 95,579 | | Cost of Revenue |
-
|
-
|
-
| 26,693 | | | Gross Profit | 1,010 | 61,191 | 35,880 | 68,886 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 16,835 | 16,461 | 14,760 | (3,877) | | Non Recurring | (45,637) | 19 | 234 | 58,083 | | Others | 4,265 | 2,427 | 3,582 | 968 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 25,547 | 42,284 | 17,304 | 13,712 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (32) | (13,588) | 13,538 | (1) | | Earnings Before Interest And Taxes | 25,547 | 28,718 | 30,870 | 17,357 | | Interest Expense | 19,130 | 20,725 | 20,839 | 21,785 | | Income Before Tax | 6,417 | 7,993 | 10,031 | (4,428) | | Income Tax Expense | 3,526 | 2,823 | 5,084 | (588) | | Minority Interest | 165 | 89 | 154 | 207 | | | | Net Income From Continuing Ops | 3,024 | 5,237 | 5,073 | (7,279) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,024 | 5,237 | 5,073 | (7,279) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,024 | $5,237 | $5,073 | ($7,279) |
|
1.52% Nasdaq 
Income Statement
